Key result
Current clinical practices result in 10-40% of patients experiencing postoperative residual weakness, highlighting the need for improved neuromuscular blockade monitoring and basic guidelines.
Population
Patients receiving neuromuscular blocking agents
Design
Review
Authors
Loading...
Alerts clinicians to ongoing risks of residual paralysis; leaves open optimal monitoring protocols and guideline implementation strategies.
Unrecognised postoperative residual neuromuscular block remains frequent, highlighting the need for improved monitoring practices and guidelines.
Naguib et al. (2017) conducted a review in Postoperative residual neuromuscular block. Neuromuscular blockade monitoring was evaluated. Current clinical practices result in 10-40% of patients experiencing postoperative residual weakness, highlighting the need for improved neuromuscular blockade monitoring and basic guidelines.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: